In alignment with a mission to broaden clinical trial access worldwide, Inato has seen major growth across its network in 2022.
Despite the nationwide incidence rate being lower than that of white women, Black women face a 41% higher death rate accompanying a breast cancer...
Inato Senior DE&I Growth Manager, Atira Goodwin sits down with Greater Gift Director of Community Outreach, Perla Nunes, for a deep dive on how we...
Community-based sites’ untapped patient populations, strong community bonds, and personal patient-physician relationships are the keys to unlocking...
With clinical trial budget negotiation being one of the biggest contributors to lost time during study start-up, a transformation towards efficiency...
To a crowded room of pharma leaders, Inato’s Liz Beatty and Otsuka’s Candace Saldarini presented their teams’ findings on how collaborating with...
Today’s clinical trials struggle to include diverse patient populations due to limited, centralized trial sites that are not easily accessible for...
Community sites bring powerful access to more patients and more diverse populations. They have many unique advantages that make them key to the...
Whether you’re focused on finding a specific type of clinical trial for your patients or working to line up more trials for your research center,...
Despite an overarching goal to save lives through medicine, the clinical trial industry leaves behind a crushing carbon footprint.